Predictive accuracy of the ASIG algorithm in a prospective systemic sclerosis cohort undergoing annual screening for pulmonary arterial hypertension

Zoe Brown,Kathleen Morrisroe,Dylan Hansen,Wendy Stevens,Susanna Proudman,Gim G Teng,Andrea Low,Mandana Nikpour
DOI: https://doi.org/10.1111/imj.16468
Abstract:The Australian Scleroderma Interest Group (ASIG) algorithm for screening pulmonary arterial hypertension (PAH) in systemic sclerosis (SSc) requires only respiratory function tests and serum N-terminal pro-brain natriuretic peptide as first-tier tests, and is recommended in international guidelines. In this communication, we present the findings of the application of the ASIG screening algorithm to a Singaporean cohort undergoing prospective annual screening for PAH, which shows a high negative predictive value. The ASIG algorithm may offer an alternative to more complex and costly SSc-PAH screening algorithms.
What problem does this paper attempt to address?